BIOMAT Database Logo BIOMAT Database Logo

Antiproteinase deficiency, emphysema and replacement therapy. 1996

J G Burdon, and K R Knight, and S Brenton, and L Cook
Department of Respiratory Medicine, St. Vincent's Hospital, Melbourne, Vic.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D010641 Phenotype The outward appearance of the individual. It is the product of interactions between genes, and between the GENOTYPE and the environment. Phenotypes
D011656 Pulmonary Emphysema Enlargement of air spaces distal to the TERMINAL BRONCHIOLES where gas-exchange normally takes place. This is usually due to destruction of the alveolar wall. Pulmonary emphysema can be classified by the location and distribution of the lesions. Emphysema, Pulmonary,Centriacinar Emphysema,Centrilobular Emphysema,Emphysemas, Pulmonary,Focal Emphysema,Panacinar Emphysema,Panlobular Emphysema,Pulmonary Emphysemas,Centriacinar Emphysemas,Centrilobular Emphysemas,Emphysema, Centriacinar,Emphysema, Centrilobular,Emphysema, Focal,Emphysema, Panacinar,Emphysema, Panlobular,Emphysemas, Centriacinar,Emphysemas, Centrilobular,Emphysemas, Focal,Emphysemas, Panacinar,Emphysemas, Panlobular,Focal Emphysemas,Panacinar Emphysemas,Panlobular Emphysemas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000515 alpha 1-Antitrypsin Plasma glycoprotein member of the serpin superfamily which inhibits TRYPSIN; NEUTROPHIL ELASTASE; and other PROTEOLYTIC ENZYMES. Trypsin Inhibitor, alpha 1-Antitrypsin,alpha 1-Protease Inhibitor,alpha 1-Proteinase Inhibitor,A1PI,Prolastin,Serpin A1,Zemaira,alpha 1 Antiprotease,alpha 1-Antiproteinase,1-Antiproteinase, alpha,Antiprotease, alpha 1,Inhibitor, alpha 1-Protease,Inhibitor, alpha 1-Proteinase,Trypsin Inhibitor, alpha 1 Antitrypsin,alpha 1 Antiproteinase,alpha 1 Antitrypsin,alpha 1 Protease Inhibitor,alpha 1 Proteinase Inhibitor
D012907 Smoking Willful or deliberate act of inhaling and exhaling SMOKE from burning substances or agents held by hand. Smoking Behaviors,Smoking Habit,Behavior, Smoking,Behaviors, Smoking,Habit, Smoking,Habits, Smoking,Smoking Behavior,Smoking Habits
D015842 Serine Proteinase Inhibitors Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. Serine Endopeptidase Inhibitor,Serine Endopeptidase Inhibitors,Serine Protease Inhibitor,Serine Protease Inhibitors,Serine Proteinase Antagonist,Serine Proteinase Antagonists,Serine Proteinase Inhibitor,Serine Proteinase Inhibitors, Endogenous,Serine Proteinase Inhibitors, Exogenous,Serine Protease Inhibitors, Endogenous,Serine Protease Inhibitors, Exogenous,Antagonist, Serine Proteinase,Endopeptidase Inhibitor, Serine,Inhibitor, Serine Endopeptidase,Inhibitor, Serine Protease,Inhibitor, Serine Proteinase,Protease Inhibitor, Serine,Proteinase Antagonist, Serine,Proteinase Inhibitor, Serine
D019896 alpha 1-Antitrypsin Deficiency Deficiency of the protease inhibitor ALPHA 1-ANTITRYPSIN that manifests primarily as PULMONARY EMPHYSEMA and LIVER CIRRHOSIS. Deficiencies, alpha 1-Antitrypsin,Deficiency, alpha 1-Antitrypsin,alpha 1 Antitrypsin Deficiency,alpha 1-Antitrypsin Deficiencies

Related Publications

J G Burdon, and K R Knight, and S Brenton, and L Cook
[Alpha 1-antitrypsin deficiency and emphysema. Replacement therapy?].
August 1989, Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke,
J G Burdon, and K R Knight, and S Brenton, and L Cook
[A case of premature emphysema with hereditary alpha-1-antiproteinase deficiency].
January 1996, Pneumonologia i alergologia polska,
J G Burdon, and K R Knight, and S Brenton, and L Cook
Emphysema in alpha1-antitrypsin deficiency: does replacement therapy affect outcome?
January 2005, Treatments in respiratory medicine,
J G Burdon, and K R Knight, and S Brenton, and L Cook
Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.
April 1987, The New England journal of medicine,
J G Burdon, and K R Knight, and S Brenton, and L Cook
[Replacement therapy of emphysema caused by alpha 1-antitrypsin deficiency].
February 1991, Medicina clinica,
J G Burdon, and K R Knight, and S Brenton, and L Cook
[Alpha 1-antiproteinase deficiency].
March 1999, Therapeutische Umschau. Revue therapeutique,
J G Burdon, and K R Knight, and S Brenton, and L Cook
[Evaluation of replacement therapy in emphysema caused by alpha 1-antitrypsin deficiency].
December 1994, Archivos de bronconeumologia,
J G Burdon, and K R Knight, and S Brenton, and L Cook
Lung antiproteinase: a potential defense against emphysema development.
February 1976, The American review of respiratory disease,
J G Burdon, and K R Knight, and S Brenton, and L Cook
Alveolar macrophage proteinase/antiproteinase expression in lung function and emphysema.
January 2014, The European respiratory journal,
J G Burdon, and K R Knight, and S Brenton, and L Cook
Pathogenesis of hereditary emphysema and replacement therapy for alpha 1-antitrypsin deficiency. Insight into the more common forms of emphysema.
December 1996, Chest,
Copied contents to your clipboard!